Clinical trial
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus…
NCT00480597 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00480597 |
|---|---|
| Title | Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer |
| Official title | Randomised, Multicenter Phase II Study in Patients With Metastatic Breast Cancer With Gemcitabine Plus Vinorelbine Versus Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Capecitabine |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine, cisplatin, vinorelbine, capecitabine |
| Enrollment | 141 |
| Start date | Oct 1, 2002 |
| First posted | May 31, 2007 |
| Last update posted | Oct 28, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: